• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » FDA authorizes OTC hearing aid software for Apple AirPods

FDA authorizes OTC hearing aid software for Apple AirPods

September 12, 2024 By Sean Whooley

Apple health features Watch AirPods Pro 2 sleep apnea hearing (1)
New features span sleep and hearing health. [Image courtesy of Apple]
The FDA announced today that it authorized the first over-the-counter (OTC) hearing aid software device, made by tech giant Apple.

Apple last week unveiled new health features for some of its technologies, including the “Hearing Aid Feature” for its AirPods Pro headphones. Once installed and customized to the user’s needs, the feature enables compatible versions of the AirPods Pro to serve as an OTC hearing aid. The headphones can amplify sounds for individuals aged 18 years or older with perceived mild to moderate hearing impairment.

FDA said the software-only mobile medical application utilizes a self-fitting strategy. Users may adjust it to meet their hearing needs without the assistance of a hearing professional. Using an iOS device, they can access the iOS HealthKit to customize the Hearing Aid Feature. There, they can refine the volume, tone and balance settings once set up.

Apple evaluated the feature in a clinical study of 118 subjects across multiple U.S. sites. Results demonstrated that subjects achieved similar perceived benefit as subjects who received professional fitting of the same device. Outcomes also included comparable performance for tests measuring levels of amplification in the ear canal and a measure of speech understanding in noise. Apple reported no adverse events related to the device.

The company plans to roll out the feature in more than 150 countries and regions — including the U.S., Europe and Japan — this month.

“Hearing loss is a significant public health issue impacting millions of Americans,” said Dr. Michelle Tarver, acting director of the FDA’s CDRH. “Today’s marketing authorization of an over-the-counter hearing aid software on a widely used consumer audio product is another step that advances the availability, accessibility and acceptability of hearing support for adults with perceived mild to moderate hearing loss.”

Filed Under: Artificial Intelligence (AI), Featured, Food & Drug Administration (FDA), Health Technology, Otolaryngology/Ear, Nose & Throat (ENT), Regulatory/Compliance, Software / IT Tagged With: Apple, FDA

More recent news

  • China reportedly launches country’s first invasive BCI trial
  • Neuralink files to raise $649M in new equity offering
  • BofA: Surgical robot remanufacturing not a major setback for Intuitive
  • InspireMD wins CE Mark approval for CGuard Prime
  • Philips reports first cases for VeriSight Pro 3D ICE catheter in Europe

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy